- Home
- MITT vs BWAY Comparison
MITT vs BWAY Comparison
Compare MITT & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITT
- BWAY
- Stock Information
- Founded
- MITT 2011
- BWAY 2003
- Country
- MITT United States
- BWAY Israel
- Employees
- MITT N/A
- BWAY N/A
- Industry
- MITT Real Estate Investment Trusts
- BWAY Medical/Dental Instruments
- Sector
- MITT Real Estate
- BWAY Health Care
- Exchange
- MITT Nasdaq
- BWAY Nasdaq
- Market Cap
- MITT 203.9M
- BWAY 177.2M
- IPO Year
- MITT 2011
- BWAY 2019
- Fundamental
- Price
- MITT $7.24
- BWAY $9.34
- Analyst Decision
- MITT Strong Buy
- BWAY Strong Buy
- Analyst Count
- MITT 5
- BWAY 3
- Target Price
- MITT $8.00
- BWAY $13.17
- AVG Volume (30 Days)
- MITT 208.7K
- BWAY 67.0K
- Earning Date
- MITT 11-05-2024
- BWAY 11-12-2024
- Dividend Yield
- MITT 10.59%
- BWAY N/A
- EPS Growth
- MITT 269.43
- BWAY N/A
- EPS
- MITT 2.09
- BWAY 0.04
- Revenue
- MITT $80,741,000.00
- BWAY $38,631,000.00
- Revenue This Year
- MITT N/A
- BWAY $378.91
- Revenue Next Year
- MITT $21.08
- BWAY $20.27
- P/E Ratio
- MITT $3.42
- BWAY $117.76
- Revenue Growth
- MITT 17.98
- BWAY 34.19
- 52 Week Low
- MITT $5.44
- BWAY $4.61
- 52 Week High
- MITT $7.95
- BWAY $10.98
- Technical
- Relative Strength Index (RSI)
- MITT 60.08
- BWAY 39.78
- Support Level
- MITT $6.91
- BWAY $9.19
- Resistance Level
- MITT $7.27
- BWAY $10.42
- Average True Range (ATR)
- MITT 0.13
- BWAY 0.36
- MACD
- MITT 0.05
- BWAY -0.10
- Stochastic Oscillator
- MITT 82.14
- BWAY 8.33
About MITT AG Mortgage Investment Trust Inc.
AG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long-term through dividends and capital appreciation. It also focuses on investing in residential mortgage-backed securities (RMBS) issued or guaranteed by a government sponsored enterprise.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.